Strategies for non-viral vectors targeting organs beyond the liver

  • Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D. & Chan, W. C. W. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J. Control. Release 240, 332–348 (2016).

    CAS 

    Google Scholar 

  • Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084–1087 (2019).

    Article 
    CAS 

    Google Scholar 

  • Gillmore, J. D. et al. CRISPR–Cas9 in vivo gene editing for transthyretin amyloidosis. N….

  • Continue Reading


    News Source: www.nature.com


    Posted

    in

    by

    Tags: